INT6868
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
Immunohistochemical examination demonstrated xanthomatous cells expressing glial fibrillary acidic protein. | |||||||||||||||
| |||||||||||||||
|
Astrocytes undergo a process of prolifiration, morphological change, and enhancement of glial fibrillary acidic protein expression, termed activation of astrocytes. | |||||||||||||||
| |||||||||||||||
|
To define the population of cells injured by paclitaxel, we examined the expression of activating transcription factor-3 (ATF3), a marker of cell injury; to define the hypertrophy of satellite cells, we quantified the expression of the intermediate filament protein glial fibrillary acidic protein (GFAP); and to define the activation of macrophages, we examined the expression of the lysosomal protein CD68. | |||||||||||||||
| |||||||||||||||
|
Immunohistochemical studies were positive for MIC-2, NSE, C-KIT, vimentin, Class III-beta tublin and glycogen, but negative for NFP, synaptophysin, chromogranin A and GFAP. | |||||||||||||||
| |||||||||||||||
|
Immortal RLT-PSC cells retained the phenotype of activated PSC proven by the expression of alpha-smooth muscle actin (alphaSMA), vimentin, desmin and glial fibrillary acidic protein (GFAP). | |||||||||||||||
| |||||||||||||||
|
Tumor cells expressed GFAP and S-100 and to lesser extent carbonic anhydrase II. | |||||||||||||||
| |||||||||||||||
|
In addition, there was an increase in the expression of glial fibrillary acidic protein (GFAP) in DRG satellite cells and an increase in the number of CD68 positive activated macrophages within the DRG and peripheral nerve. | |||||||||||||||
| |||||||||||||||
|
RESULTS AND CONCLUSION: Immunohistochemical glial fibrillary acid protein (GFAP) expression was seen only in the glioblastoma portion. | |||||||||||||||
| |||||||||||||||
|
Type II cells were identified in only one of five high-grade (malignant) paragangliomas and that tumor contained vanishingly rare cells that were weakly S-100 protein positive but GFAP negative. | |||||||||||||||
| |||||||||||||||
|
Early lesions displayed abundant Gfap-positive cells, although the larger tumors partly lost the expression of Gfap. | |||||||||||||||
| |||||||||||||||
|
Dissociation of these neurospheres and removal of mitogens results in expression of the characteristic Schwann cell markers S100 and p75 nerve growth factor receptor and GFAP. | |||||||||||||||
| |||||||||||||||
|
Immunohistochemically, the tumor cells were diffusely and strongly positive for epithelial membrane antigen and vimentin, and showed focal expression of glial fibrillary acidic protein, pancytokeratin, and neurofilament protein. | |||||||||||||||
| |||||||||||||||
|
CD34 and CD117 were used to exclude a gastrointestinal stromal tumour, whereas GFAP expression confirmed neural differentiation. | |||||||||||||||
| |||||||||||||||
|
We found the expression of human GAPDH, GFAP, NG2, TUJ1, and MAP2 but not in the control rats or nonlesioned part of the spinal cord (Supporting Information Fig. 5) confirming the presence of differentiated hESC. | |||||||||||||||
| |||||||||||||||
|
These cells finally matured to astrocytes, oligodendrocytes, and neurons (expressing GFAP, NG2, and TUJ1, respectively; Supporting Information Fig. 5) but only OPC and OPC + MP expressed human MAP2 (marker for postmitotic neurons), which is an additional proof of a triple fate of OPC and MP.
| |||||||||||||||
| |||||||||||||||
|
Immortal RLT-PSC cells retained the phenotype of activated PSC proven by the expression of alpha-smooth muscle actin (alphaSMA), vimentin, desmin and glial fibrillary acidic protein (GFAP). | |||||||||||||||
| |||||||||||||||
|
S-100 protein, SMA and GFAP were negative. | |||||||||||||||
| |||||||||||||||
|
Immunohistochemically, the tumor cells were positive for glial fibrillary acidic protein (GFAP), epithelial membrane antigen (EMA), vimentin, and negative for cytokeratin, synaptophysin. | |||||||||||||||
| |||||||||||||||
|
The surrounding hepatic tissue was negative for GFAP. | |||||||||||||||
| |||||||||||||||
|
Immunohistochemically, the neoplastic cells were positive for S-100 protein (diffuse and strong), CD34 (primarily in Antoni B areas), glial fibrillary acidic protein (GFAP; weak and diffuse) and calretinin (mainly in Antoni A areas), while none was positive for CD31, estrogen and progesterone receptors, bcl-2, or epithelial membrane antigen (EMA). | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.